New pneumonia vaccine under safety watch in japanese infants
NCT ID NCT06622109
First seen Jan 05, 2026 · Last updated May 19, 2026 · Updated 15 times
Summary
This study checks the safety of the PREVENAR 20 vaccine in infants aged 2 to 6 months in Japan. About 1,100 babies will receive four doses as part of their routine shots. Researchers will track any side effects from the first dose until 28 days after the last dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Tokyo, 151-8589, Japan
Conditions
Explore the condition pages connected to this study.